The sor Gene of HIV-1 Is Required for Efficient Virus Transmission in Vitro
Abstract
The genome of the human immunodeficiency virus HIV-1 contains at least eight genes, of which three (sor, R, and 3′orf) have no known function. In this study, the role of the sor gene was examined by constructing a series of proviral genomes of HIV-1 that either lacked the coding sequences for sor or contained point mutations in sor. Analysis of four such mutants revealed that although each clone could generate morphologically normal virus particles upon transfection, the mutant viruses were limited in their capacity to establish stable infection. Virus derived from transfection of Cos-1 cells (OKT4-) with sor mutant proviral DNA's was resistant to transmission to OKT4+ "susceptible" cells under cell-free conditions, and was transmitted poorly by coculture. In contrast, virus derived from clones with an intact sor frame was readily propagated by either approach. Normal amounts of gag-, env-, and pol-derived proteins were produced by all four mutants and assays in both lymphoid and nonlymphoid cells indicated that their trans-activating capacity was intact and comparable with wild type. Thus the sor gene, although not absolutely required in HIV virion formation, influences virus transmission in vitro and is crucial in the efficient generation of infectious virus. The data also suggest that sor influences virus replication at a novel, post-translational stage and that its action is independent of the regulatory genes tat and trs.
References
ALLAN, J.S., MAJOR GLYCOPROTEIN ANTIGENS THAT INDUCE ANTIBODIES IN AIDS PATIENTS ARE ENCODED BY HTLV-III, SCIENCE 228: 1091 (1985).
ARYA, S.K., TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III), SCIENCE 229: 69 (1985).
BARIN, F, VIRUS ENVELOPE PROTEIN OF HTLV-III REPRESENTS MAJOR TARGET ANTIGEN FOR ANTIBODIES IN AIDS PATIENTS, SCIENCE 228: 1094 (1985).
CHIRGWIN, J.M., ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE, BIOCHEMISTRY 18: 5294 (1979).
CULLEN, B.R., TRANSACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS OCCURS VIA A BIMODAL MECHANISM, CELL 46: 973 (1986).
FEINBERG, M, CELL 47: 807 (1986).
FISHER, A.G., A MOLECULAR CLONE OF HTLV-III WITH BIOLOGICAL-ACTIVITY, NATURE 316: 262 (1985).
FISHER, A.G., THE TRANSACTIVATOR GENE OF HTLV-III IS ESSENTIAL FOR VIRUS-REPLICATION, NATURE 320: 367 (1986).
Franchini, G., Nature 328: 539 (1987).
GLUZMAN, Y, SV40-TRANSFORMED SIMIAN CELLS SUPPORT THE REPLICATION OF EARLY SV40 MUTANTS, CELL 23: 175 (1981).
GONDA, M.A., HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III SHARES SEQUENCE HOMOLOGY WITH A FAMILY OF PATHOGENIC LENTIVIRUSES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 83: 4007 (1986).
GONDA, M.A., SEQUENCE HOMOLOGY AND MORPHOLOGIC SIMILARITY OF HTLV-III AND VISNA VIRUS, A PATHOGENIC LENTI-VIRUS, SCIENCE 227: 173 (1985).
GORMAN, C.M., RECOMBINANT GENOMES WHICH EXPRESS CHLORAMPHENICOL ACETYLTRANSFERASE IN MAMMALIAN-CELLS, MOLECULAR AND CELLULAR BIOLOGY 2: 1044 (1982).
Gorman, C. M., Proceedings of the National Academy of Sciences of the United States of America 79: 6777 (1982).
GRAHAM, F.L., SIZE AND LOCATION OF TRANSFORMING REGION IN HUMAN ADENOVIRUS TYPE 5 DNA, NATURE 251: 687 (1974).
GRAHAM, F.L., NEW TECHNIQUE FOR ASSAY OF INFECTIVITY OF HUMAN ADENOVIRUS 5 DNA, VIROLOGY 52: 456 (1973).
GUYADER, M, GENOME ORGANIZATION AND TRANSACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2, NATURE 326: 662 (1987).
HAHN, B.H., MOLECULAR-CLONING AND CHARACTERIZATION OF THE HTLV-III VIRUS ASSOCIATED WITH AIDS, NATURE 312: 166 (1984).
IVANOFF, L.A., EXPRESSION AND SITE-SPECIFIC MUTAGENESIS OF THE POLIOVIRUS 3C PROTEASE IN ESCHERICHIA-COLI, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 83: 5392 (1986).
KAN, N.C., IDENTIFICATION OF HTLV-III/LAV SOR GENE-PRODUCT AND DETECTION OF ANTIBODIES IN HUMAN-SERA, SCIENCE 231: 1553 (1986).
LEE, T.H., A NEW HTLV-III/LAV PROTEIN ENCODED BY A GENE FOUND IN CYTOPATHIC RETROVIRUSES, SCIENCE 231: 1546 (1986).
Maniatis, T., Molecular Cloning: A Laboratory Manual (1982).
MUESING, M.A., NUCLEIC-ACID STRUCTURE AND EXPRESSION OF THE HUMAN AIDS LYMPHADENOPATHY RETROVIRUS, NATURE 313: 450 (1985).
OKAMOTO, T, DEMONSTRATION OF VIRUS-SPECIFIC TRANSCRIPTIONAL ACTIVATOR(S) IN CELLS INFECTED WITH HTLV-III BY AN INVITRO CELL-FREE SYSTEM, CELL 47: 29 (1986).
PYPER, J.M., SEQUENCE HOMOLOGY BETWEEN CLONED CAPRINE ARTHRITIS ENCEPHALITIS-VIRUS AND VISNA VIRUS, 2 NEUROTROPIC LENTIVIRUSES, JOURNAL OF VIROLOGY 58: 665 (1986).
QUEEN, C, IMMUNOGLOBULIN GENE-TRANSCRIPTION IS ACTIVATED BY DOWNSTREAM SEQUENCE ELEMENTS, CELL 33: 741 (1983).
RATNER, L, COMPLETE NUCLEOTIDE-SEQUENCE OF THE AIDS VIRUS, HTLV-III, NATURE 313: 277 (1985).
RHO, H.M., CHARACTERIZATION OF THE REVERSE-TRANSCRIPTASE FROM A NEW RETROVIRUS (HTLV) PRODUCED BY A HUMAN CUTANEOUS T-CELL LYMPHOMA CELL-LINE, VIROLOGY 112: 355 (1981).
SALINOVICH, O, RAPID EMERGENCE OF NOVEL ANTIGENIC AND GENETIC-VARIANTS OF EQUINE INFECTIOUS-ANEMIA VIRUS DURING PERSISTENT INFECTION, JOURNAL OF VIROLOGY 57: 71 (1986).
SANCHEZPESCADOR, R, NUCLEOTIDE-SEQUENCE AND EXPRESSION OF AN AIDS-ASSOCIATED RETROVIRUS (ARV-2), SCIENCE 227: 484 (1985).
SHAW, G.M., MOLECULAR CHARACTERIZATION OF HUMAN T-CELL LEUKEMIA (LYMPHOTROPIC) VIRUS TYPE-III IN THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME, SCIENCE 226: 1165 (1984).
SODROSKI, J, REPLICATIVE AND CYTOPATHIC POTENTIAL OF HTLV-III/LAV WITH SOR GENE DELETIONS, SCIENCE 231: 1549 (1986).
SONIGO, P, NUCLEOTIDE-SEQUENCE OF THE VISNA LENTIVIRUS - RELATIONSHIP TO THE AIDS VIRUS, CELL 42: 369 (1985).
VERONESE, F.D., MONOCLONAL-ANTIBODIES SPECIFIC FOR P24, THE MAJOR CORE PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-III, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 82: 5199 (1985).
WAINHOBSON, S, NUCLEOTIDE-SEQUENCE OF THE AIDS VIRUS, LAV, CELL 40: 9 (1985).
WONGSTAAL, F, HUMAN T-LYMPHOTROPIC RETROVIRUSES, NATURE 317: 395 (1985).
Get full access to this article
View all available purchase options and get full access to this article.
Already a Subscriber?Sign In
Information & Authors
Information
Published In

Science
Volume 237 | Issue 4817
21 August 1987
21 August 1987
Copyright
© 1987.
Submission history
Published in print: 21 August 1987
Authors
Metrics & Citations
Metrics
Article Usage
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Editing at the Crossroad of Innate and Adaptive Immunity, Science, 307, 5712, (1061-1065), (2021)./doi/10.1126/science.1105964
- Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex, Science, 302, 5647, (1056-1060), (2021)./doi/10.1126/science.1089591
- Weapons of Mutational Destruction, Science, 301, 5635, (923-925), (2003)./doi/10.1126/science.1088965
- Molecular Targets for AIDS Therapy, Science, 249, 4976, (1533-1544), (1990)./doi/10.1126/science.1699273
- Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus, Science, 241, 4863, (357-359), (1988)./doi/10.1126/science.3388046
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis, Science, 239, 4840, (617-622), (1988)./doi/10.1126/science.3277274
- Retroviruses, Science, 240, 4858, (1427-1435), (1988)./doi/10.1126/science.3287617
Loading...
View Options
Get Access
Log in to view the full text
AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.
- Become a AAAS Member
- Activate your AAAS ID
- Purchase Access to Other Journals in the Science Family
- Account Help
Log in via OpenAthens.
Log in via Shibboleth.
More options
Purchase digital access to this article
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
View options
PDF format
Download this article as a PDF file
Download PDF





